Swiss Re AG
OTC:SSREY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
OTC:SSREY
|
CH |
|
Certara Inc
NASDAQ:CERT
|
US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
C
|
China Minsheng Banking Corp Ltd
F:GHFH
|
CN |
|
Varia US Properties AG
SIX:VARN
|
CH |
Wall St Price Targets
SSREY Price Targets Summary
Swiss Re AG
According to Wall Street analysts, the average 1-year price target for SSREY is 42.7 USD with a low forecast of 37.14 USD and a high forecast of 54.19 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SSREY's stock price target?
Price Target
42.7
USD
According to Wall Street analysts, the average 1-year price target for SSREY is 42.7 USD with a low forecast of 37.14 USD and a high forecast of 54.19 USD.
What is the Revenue forecast for Swiss Re AG?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Swiss Re AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 6%.
